Call Options

26 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.54 - $5.47 $2,124 - $3,282
600 Added 1.52%
40,000 $158,000
Q2 2024

Aug 14, 2024

BUY
$3.04 - $4.23 $36,176 - $50,337
11,900 Added 43.27%
39,400 $159,000
Q1 2024

May 15, 2024

BUY
$2.88 - $4.89 $2,016 - $3,423
700 Added 2.61%
27,500 $94,000
Q4 2023

Feb 14, 2024

SELL
$1.08 - $3.63 $1,296 - $4,356
-1,200 Reduced 4.29%
26,800 $87,000
Q3 2023

Nov 15, 2023

BUY
$2.81 - $5.69 $2,248 - $4,552
800 Added 2.94%
28,000 $81,000
Q2 2023

Aug 23, 2023

SELL
$4.45 - $7.57 $89,000 - $151,400
-20,000 Reduced 42.37%
27,200 $147,000
Q1 2023

May 15, 2023

BUY
$2.48 - $5.22 $117,056 - $246,384
47,200 New
47,200 $210,000
Q2 2022

Aug 15, 2022

SELL
$1.92 - $6.28 $59,520 - $194,680
-31,000 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$5.07 - $7.2 $157,170 - $223,200
31,000 New
31,000 $188,000
Q4 2021

Feb 14, 2022

SELL
$5.67 - $8.54 $124,173 - $187,025
-21,900 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$13.4 - $16.3 $21,440 - $26,080
-1,600 Reduced 6.81%
21,900 $293,000
Q2 2021

Aug 06, 2021

BUY
$14.81 - $19.13 $41,468 - $53,564
2,800 Added 13.53%
23,500 $354,000
Q1 2021

May 14, 2021

SELL
$14.52 - $23.53 $81,312 - $131,768
-5,600 Reduced 21.29%
20,700 $368,000
Q4 2020

Feb 12, 2021

SELL
$10.14 - $15.19 $244,374 - $366,079
-24,100 Reduced 47.82%
26,300 $382,000
Q3 2020

Nov 13, 2020

BUY
$9.57 - $21.32 $298,584 - $665,184
31,200 Added 162.5%
50,400 $482,000
Q2 2020

Aug 13, 2020

SELL
$12.21 - $16.99 $500,610 - $696,589
-41,000 Reduced 68.11%
19,200 $278,000
Q1 2020

May 11, 2020

SELL
$9.03 - $19.72 $467,753 - $1.02 Million
-51,800 Reduced 46.25%
60,200 $686,000
Q4 2019

Feb 12, 2020

BUY
$13.01 - $17.15 $1.46 Million - $1.92 Million
112,000 New
112,000 $1.63 Million
Q3 2019

Nov 14, 2019

SELL
$14.55 - $20.56 $900,645 - $1.27 Million
-61,900 Closed
0 $0
Q2 2019

Aug 20, 2019

SELL
$15.0 - $19.62 $189,000 - $247,212
-12,600 Reduced 16.91%
61,900 $971,000
Q1 2019

May 15, 2019

SELL
$11.65 - $17.72 $81,550 - $124,039
-7,000 Reduced 8.59%
74,500 $1.29 Million
Q4 2018

Feb 14, 2019

BUY
$10.72 - $16.73 $873,680 - $1.36 Million
81,500 New
81,500 $944,000
Q3 2018

Nov 14, 2018

SELL
$17.73 - $26.69 $2.29 Million - $3.45 Million
-129,400 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$9.0 - $20.16 $585,000 - $1.31 Million
65,000 Added 100.93%
129,400 $1.45 Million
Q4 2017

Feb 14, 2018

SELL
$13.26 - $22.86 $132,600 - $228,600
-10,000 Reduced 13.44%
64,400 $1.25 Million
Q3 2017

Nov 15, 2017

BUY
$19.76 - $24.9 $1.47 Million - $1.85 Million
74,400
74,400 $1.61 Million

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $684M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.